The Advisory Board referred to in Articles L. 3111-9 and L. 3122-1 shall exercise the same powers in relation to the Board of Directors of the Office, in respect of the damage referred to in the third paragraph of Article L. 1142-22, the same powers as for questions relating to compensation for losses resulting from contamination by the hepatitis B or C virus, the human T-lymphotropic virus or the human immunodeficiency virus caused by a transfusion of blood products or an injection of blood-derived medicinal products, losses directly attributable to a compulsory vaccination carried out in application of Article L. 3111-4 and damage attributable to a preventive, diagnostic or care activity carried out in application of measures taken in accordance with articles L. 3131-1 or L. 3134-1.
When questions relating to compensation for the damage mentioned in the third paragraph of article L. 1142-22 are referred to the Orientation Council, its composition is adapted to these questions, under conditions determined by decree of the Conseil d’Etat.